Evidence map›Paper›PMID 34566558›Full record

ReviewFrontiers in neuroscience2021

Ketamine: Neuroprotective or Neurotoxic?

Divya Choudhury, Anita E Autry, Kimberley F Tolias, Vaishnav Krishnan

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in neuroscience, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed, 4 pooled it
6.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 4 syntheses or guidelines pooled it, 63 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Divya ChoudhuryDepartment of BioSciences, Rice University, Houston, TX, United States.
Anita E AutryDominick P. Purpura Department of Neuroscience, Albert Einstein College of Medicine, Bronx, NY, United States.
Kimberley F ToliasDepartment of Neuroscience, Baylor College of Medicine, Houston, TX, United States.
Vaishnav KrishnanDepartment of Neuroscience, Baylor College of Medicine, Houston, TX, United States.
Baylor College of Medicine · USAlbert Einstein College of Medicine · USRice University · US

Funding

SUPPORT FOR THE ROSE F KENNEDY IDDRC P50P50HD105352 · NICHD · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI SOPHIE MOLHOLM, Steven Upshaw Walkley · 2021 to 2026
$7.0M
Signaling Mechanisms Regulating Rho GTPase-Dependent Synaptic Plasticity Underlying Memory in Health and DiseaseR01NS062829 · NINDS · BAYLOR COLLEGE OF MEDICINE · PI TOLIAS, KIMBERLY R · 2009 to 2025
$4.4M
Adhesion-GPCRs: Regulators of dendritic development, synaptogenesis and mental healthR01MH109511 · NIMH · BAYLOR COLLEGE OF MEDICINE · PI TOLIAS, KIMBERLY R · 2017 to 2021
$2.0M
Signaling Mechanisms Regulating Rho GTPase-Dependent Synaptic Plasticity Underlying Memory in Health and DiseaseRF1NS062829 · NINDS · BAYLOR COLLEGE OF MEDICINE · PI TOLIAS, KIMBERLY R · 2022 to 2022
$1.9M
NICHD NIH HHS P50 HD105352NIMH NIH HHS R01 MH109511NINDS NIH HHS R01 NS062829NINDS NIH HHS RF1 NS062829
6 · The paper itself

Abstract

Ketamine, a non-competitive

Indexed as

AMPA receptorantidepressantBDNFketamine-induced neurotoxicityketamine mechanismneuroprotectionNMDA receptor

Identifiers

PMID34566558
PMCPMC8461018
OpenAlexW3199420066

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.